Nuvo Pharmaceuticals Inc NRIFF

Horla

[blackascanbe]

You should factor in that Pennsaid has another 21/2 years (approx.) of exclusivity. Phase 2 trials are being conducted to expand the applications for Pennsaid gel beyond knees. Pennsaid gel availabilty will dovetail rather well as the protection for pennsaid expires. Just watch what happens before the end of September. I obviously can't say more than that. Maybe we should just all be patient and see what happens or sell. Since you are of the opinion that management is not being forthcoming with information perhaps you could enlighten me on what they are not being forthcoming about.